A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis

Inclusion Criteria:

- Male or female subjects between 18 and 65 years of age (inclusive).

- A diagnosis of AD, meeting the Guidelines for Diagnosis of Atopic Dermatitis criteria

Exclusion Criteria:

- Taking systemic immunosuppressive drugs or biologicals (within 3 months), or systemic
corticosteroids therapy (within 4 weeks)prior to Screening(note: inhaled, intranasal
or otic corticosteroids are allowed).

- Use of phototherapy or tanning beds within 6 weeks of screening

- History of reactive airway disease (asthma) requiring hospitalization in an intensive
care unit in the last 5 years.

- Presence of a clinically significant disorder involving the cardiovascular,
respiratory, renal, gastrointestinal, immunologic, hematologic, endocrine, or
neurologic system(s) or psychiatric disease (as determined by the Clinical
Investigator) that will interfere with interpretation of data from this patient (eg,
renal impairment with non-atopic pruritis).